Nowadays, Coronavirus (Coronavirus Disease 2019, COVID 19) is a new global problem. Coronavirus has spread to the world more than the first infection started country. Continue reading The changing market needs and sales channel according to environment situations.
As every year in this Period, the French syndicate of food supplements producers, SYNADIET, published the activity report of the previous year.
Continue reading Synadiet Report 2019: where we go…
Independent registration from the global public health organization demonstrates a commitment to dietary supplement quality and compliance with U.S. GMP requirements
Continue reading Monteloeder S.L. Earns NSF International’s Good Manufacturing Practice Registration
The main focus of public attention right now focuses on the coronavirus pandemic.
Coronavirus COVID-19 is a new type of coronavirus that was first detected last December in the city of Wuhan, Hubei Province, in China. The source of infection is under investigation.
Continue reading China: Coronavirus increases sales of supplements for the immune system
Monteloeder has been awarded by the USP (United States Pharmacopeia) for contributing in its “Donor Recognition Program” in the development of USP Monographs for Dietary Supplements and in the manufacture of Primary Reference Standards.
Continue reading USP recognition award to Monteloeder
On November 11, the MFDA (Ministry of Food and Drug Safety) has approved the health claim “May help to maintain skin health from skin damaged by UV radiation” for Nutroxsun. This has been possible due to the good work of the Korean company Natural F&P, that from the beginning informed Monteloeder that their main goal was to get the health claim approved.
Continue reading Nutroxsun® has obtained the health claim in South Korea for UV protection
In November 2012, in Cambodia, the ten countries that make up ASEAN (Brunei, Malaysia, Singapore, Thailand, Philippines, Indonesia, Lao PDR, Cambodia, Vietnam and Myammar) began negotiations to promote trade with six other countries in the area, specifically with Australia, New Zealand, China, Japan, South Korea and India.
Continue reading RECP: The world’s largest trade agreement will strengthen exchanges in the Pacific
It is a pleasure to announce the launch in Italy by PL Pharma S.r.l. of the product PREXURA®: food supplement in tablet form containing Metabolaid®, co-enzime Q10 and vitamin D3.
Continue reading Launch of Prexura® in Italy
In early September 2019, our partner in Taiwan, Newin had organized a seminar for Metabolaid in the effort of promotion across Taiwanese market. The keynote for Metabolaid was delivered by our R&D, Digital Health Scientific Advisor, Dr. Jonathan Jones.
Continue reading METABOLAID SEMINAR IN TAIWAN